Artículos con órdenes de acceso público - Jason LiMás información
No disponibles en ningún lugar: 5
Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma
R Agarwal, YC Chan, CS Tam, T Hunter, D Vassiliadis, CE Teh, ...
Nature medicine 25 (1), 119-129, 2019
Órdenes: Swiss National Science Foundation, Howard Hughes Medical Institute, National …
A pharmacogenomic approach validates AG-221 as an effective and on-target therapy in IDH2 mutant AML
LM Kats, SJ Vervoort, R Cole, AJ Rogers, GP Gregory, E Vidacs, J Li, ...
Leukemia 31 (6), 1466-1470, 2017
Órdenes: National Health and Medical Research Council, Australia
HDAC Inhibitor Panobinostat Engages Host Innate Immune Defenses to Promote the Tumoricidal Effects of Trastuzumab in HER2+ TumorsPanobinostat Enhances the Curative Activity of …
M Medon, E Vidacs, SJ Vervoort, J Li, MR Jenkins, KM Ramsbottom, ...
Cancer research 77 (10), 2594-2606, 2017
Órdenes: National Health and Medical Research Council, Australia
Mutations in RECQL are not associated with breast cancer risk in an Australian population
N Li, SM Rowley, DL Goode, KC Amarasinghe, S McInerny, L Devereux, ...
Nature genetics 50 (10), 1346-1348, 2018
Órdenes: National Health and Medical Research Council, Australia
Searching for candidate genes in familial BRCAX mutation carriers with prostate cancer
SM Hunter, SM Rowley, D Clouston, J Li, R Lupat, N Krishnananthan, ...
Urologic Oncology: Seminars and Original Investigations 34 (3), 120. e9-120. e16, 2016
Órdenes: National Health and Medical Research Council, Australia
Disponibles en algún lugar: 47
UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas
SQ Wong, K Waldeck, IA Vergara, J Schröder, J Madore, JS Wilmott, ...
Cancer research 75 (24), 5228-5234, 2015
Órdenes: National Health and Medical Research Council, Australia
Response of BRAF-Mutant Melanoma to BRAF Inhibition Is Mediated by a Network of Transcriptional Regulators of GlycolysisRole of Glycolysis in Responses to BRAF Inhibition
TJ Parmenter, M Kleinschmidt, KM Kinross, ST Bond, J Li, MR Kaadige, ...
Cancer discovery 4 (4), 423-433, 2014
Órdenes: US National Institutes of Health, National Health and Medical Research …
Functional and molecular characterisation of EO771. LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer
CN Johnstone, YE Smith, Y Cao, AD Burrows, RSN Cross, X Ling, ...
Disease models & mechanisms 8 (3), 237-251, 2015
Órdenes: National Health and Medical Research Council, Australia, Higher Education …
BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1
SJ Hogg, SJ Vervoort, S Deswal, CJ Ott, J Li, LA Cluse, PA Beavis, ...
Cell Reports 18 (9), 2162-2174, 2017
Órdenes: Austrian Science Fund, National Health and Medical Research Council …
A role for pericytes as microenvironmental regulators of human skin tissue regeneration
S Paquet-Fifield, H Schlüter, A Li, T Aitken, P Gangatirkar, D Blashki, ...
The Journal of clinical investigation 119 (9), 2795-2806, 2009
Órdenes: US National Institutes of Health
Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes
SM Hunter, MS Anglesio, GL Ryland, R Sharma, YE Chiew, SM Rowley, ...
Oncotarget 6 (35), 37663, 2015
Órdenes: National Health and Medical Research Council, Australia
The architecture and evolution of cancer neochromosomes
DW Garsed, OJ Marshall, VDA Corbin, A Hsu, L Di Stefano, J Schröder, ...
Cancer cell 26 (5), 653-667, 2014
Órdenes: National Health and Medical Research Council, Australia
Loss of heterozygosity: what is it good for?
GL Ryland, MA Doyle, D Goode, SE Boyle, DYH Choong, SM Rowley, J Li, ...
BMC medical genomics 8 (1), 1-12, 2015
Órdenes: National Health and Medical Research Council, Australia
Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
GL Ryland, SM Hunter, MA Doyle, F Caramia, J Li, SM Rowley, M Christie, ...
Genome medicine 7 (1), 1-12, 2015
Órdenes: National Health and Medical Research Council, Australia
BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV DamageMutation Load in BRAF/NRAS Wild-Type Melanomas
VJ Mar, SQ Wong, J Li, RA Scolyer, C McLean, AT Papenfuss, RW Tothill, ...
Clinical Cancer Research 19 (17), 4589-4598, 2013
Órdenes: National Health and Medical Research Council, Australia
Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor …
GP Risbridger, RA Taylor, D Clouston, A Sliwinski, H Thorne, S Hunter, ...
European urology 67 (3), 496-503, 2015
Órdenes: National Health and Medical Research Council, Australia
The molecular origin and taxonomy of mucinous ovarian carcinoma
D Cheasley, MJ Wakefield, GL Ryland, PE Allan, K Alsop, ...
Nature communications 10 (1), 1-11, 2019
Órdenes: US Department of Defense, US National Institutes of Health, National Health …
Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA
L Tan, S Sandhu, RJ Lee, J Li, J Callahan, S Ftouni, N Dhomen, ...
Annals of Oncology 30 (5), 804-814, 2019
Órdenes: National Health and Medical Research Council, Australia, Cancer Research UK …
Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates
H Do, SQ Wong, J Li, A Dobrovic
Clinical chemistry 59 (9), 1376-1383, 2013
Órdenes: National Health and Medical Research Council, Australia
Massively‐parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary
RW Tothill, J Li, L Mileshkin, K Doig, T Siganakis, P Cowin, A Fellowes, ...
The Journal of pathology 231 (4), 413-423, 2013
Órdenes: Australian Research Council
La información de publicación y financiación se determina de forma automática mediante un programa informático